Grant: Discovery Grants Program - Individual
University of Toronto
$25,000.00
Neurogenetic Control of Amygdala Functions
EF 2012-13
Résumé
The amygdala is a key brain region for the behavioral expression of fear and anxiety. Many receptors that influence fear and anxiety (such as cannabinoid and CCK receptors) are expressed on basolateral amygdala inhibitory neurons that have been recently identified. We propose to study two types of inhibitory neurons (those expressing the panic-inducing neuropeptide CCK or the calcium-binding protein Parvalbumin) using new genetic methods to control these neurons. These methods use a virus, called adeno-associated virus, to pass specially designed muscarinic receptor genes into mouse amygdala neurons. Once these receptors are expressed on CCK or Parvalbumin GABA neurons, the neurons can be excited or inhibited by a drug administered systemically. These methods are designed to understand how genetically defined neurons and receptors control emotions, in particular fear and anxiety measured behaviorally. We will test these genetically-activated or genetically-inhibited mice using startle reflex, elevated plus maze, open-field locomotion and conditioned fear tasks. Then we will study how these mice respond to intra-amygdala treatments that affect startle, fear and anxiety, to determine how much these neurons influence sensitivity to oxytocin, cannabinoids or CCK receptor blockers.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
7077-2012
Name nom
Yeomans, John
Department département
Psychology (St. George Campus)
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2012
Award amount
25000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1502
Committee name en
Biological Systems and Functions
Committee name fr
Systèmes et fonctions biologiques
Area of application code
1210
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Psychology
Area of application fr
Psychologie
Research subject code
6308
Research subject group en
Psychology
Research subject group fr
Psychologie
Research subject en
Behavioural neuroscience
Research subject fr
Neurologie du comportement
Partie
1
Nb partie
5
Application title
Neurogenetic Control of Amygdala Functions
Keyword
NSERC
Application summary
The amygdala is a key brain region for the behavioral expression of fear and anxiety. Many receptors that influence fear and anxiety (such as cannabinoid and CCK receptors) are expressed on basolateral amygdala inhibitory neurons that have been recently identified. We propose to study two types of inhibitory neurons (those expressing the panic-inducing neuropeptide CCK or the calcium-binding protein Parvalbumin) using new genetic methods to control these neurons. These methods use a virus, called adeno-associated virus, to pass specially designed muscarinic receptor genes into mouse amygdala neurons. Once these receptors are expressed on CCK or Parvalbumin GABA neurons, the neurons can be excited or inhibited by a drug administered systemically. These methods are designed to understand how genetically defined neurons and receptors control emotions, in particular fear and anxiety measured behaviorally. We will test these genetically-activated or genetically-inhibited mice using startle reflex, elevated plus maze, open-field locomotion and conditioned fear tasks. Then we will study how these mice respond to intra-amygdala treatments that affect startle, fear and anxiety, to determine how much these neurons influence sensitivity to oxytocin, cannabinoids or CCK receptor blockers.